EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals.

[1]  K. Young,et al.  EBV-positive diffuse large B-cell lymphoma of the elderly. , 2013, Blood.

[2]  M. Hino,et al.  Epstein–barr virus in diffuse large B‐Cell lymphoma in immunocompetent patients in Japan is as low as in Western Countries , 2011, Journal of medical virology.

[3]  Kai Fu,et al.  Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Castillo,et al.  Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America , 2011, Leukemia & lymphoma.

[5]  Y. Kagami,et al.  Increased Peripheral T Cell Responses to EBV-Infected Cells with Frequent Detection of EBV-DNA In Plasma and Viral mRNA In Peripheral B-Cells In Immunocompetent EBV-Positive Diffuse Large B-Cell Lymphoma Patients , 2010 .

[6]  A. Rosato,et al.  Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors , 2010, The Journal of Immunology.

[7]  J. Butera,et al.  Epstein–Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma , 2010, Leukemia & lymphoma.

[8]  E. Hsi,et al.  Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. , 2009, Human pathology.

[9]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[10]  L. Pantanowitz,et al.  HIV‐associated plasmablastic lymphoma: Lessons learned from 112 published cases , 2008, American journal of hematology.

[11]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[12]  T. Naoe,et al.  Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients , 2007, Clinical Cancer Research.

[13]  J. Ahn,et al.  The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. , 2007, Blood.

[14]  J. Cohen,et al.  Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells , 2007, Journal of Virology.

[15]  C. Klein,et al.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. , 2007, Blood.

[16]  Gouri Nanjangud,et al.  Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. , 2006, Blood.

[17]  J. Cohen,et al.  Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Meland,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[19]  J. Aster,et al.  Molecular biology of Burkitt's lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Armitage.  The changing classification of non‐Hodgkin's lymphomas , 1997, CA: a cancer journal for clinicians.

[21]  P. Gaulard,et al.  Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas. , 1996, Leukemia.

[22]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[23]  S. Hamilton-Dutoit,et al.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.

[24]  J. Butera,et al.  Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. , 2011, The oncologist.

[25]  M. Bissell.  Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations , 2011 .

[26]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[27]  M. Tiemann,et al.  Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. , 1992, Blood.